SELLAS Life Sciences: REGAL Readout Catalyst

Micro cap biotech SELLAS has a pivotal REGAL readout approaching. Recent article highlights ownership structure changes and balance sheet improvements, signaling potential institutional interest or activist involvement. This is a catalyst-driven play with a defined timeline, requiring close monitoring for readout date and shareholder shifts.